{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-035728","form_type":"8-K","ticker":"IMMX","cik":"0001873835","company_name":"Immix Biopharma, Inc.","filed_at":"2022-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.872932+00:00","generated_at":"2026-06-21T03:43:07.648225+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Immix Biopharma to use Nexcella slide presentation in investor meetings; no specifics given","bullets":["Slide presentation of wholly-owned subsidiary Nexcella to be used in third-party meetings.","No financial or operational details from the presentation are included in the filing.","Event is a routine FD disclosure; no substantive news provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-035728","json":"https://secwatch.observer/filing/0001493152-22-035728.json","markdown":"https://secwatch.observer/filing/0001493152-22-035728.md","text":"https://secwatch.observer/filing/0001493152-22-035728.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873835/000149315222035728/0001493152-22-035728-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873835/000149315222035728/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T03:43:07.648225+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}